In another recent study performed on normoxic lung cancer cells, angiogenic parameters of HUVECs were reduced by CM of lung cancer cells previously incubated with MAGL inhibitors, with the release of antiangiogenic TIMP-1 playing a critical role in this process [13]. The gene discussed is TIMP1; the disease is lung carcinoma.